Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Esophagitis × Glutamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Peripheral Nervous System Diseases 2 Mucositis 2 Head and Neck Neoplasms 2 Vaso-Occlusive Crises 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Pain 1 Gastrointestinal Neoplasms 1 Esophagitis 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Surveys and Questionnaires 1 Immunonutrition Diet 1 Glutamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated

77 enrolled 28 charts

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡